Although rates of mental health conditions rose drastically during the onset of the pandemic, a study shows that those who used psychedelics were less impacted. A study on the COVID-19...
In late April 2026 the FDA issued National Priority Vouchers to three psychedelic programs — Compass Pathways’ COMP360, Usona Institute’s psilocybin, and Transcend Therapeutics’ methylone — after a Trump executive...
Ancient Wisdom Meets Modern Science: Lessons from Indigenous Plant Medicine for Today’s Psychedelic Renaissance For over 10,000 years, ancient cultures and indigenous communities have utilized plant medicines to heal, connect,...
